Lifecore Biomedical Inc (LFCR) Noticias

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen...

Lifecore Biomedical Hosts Virtual Investor Day

CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Lifecore Biomedical to Present at Stephens Annual Investment Conference

CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024

CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a...

Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations

Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities